Personal information

No personal information available

Activities

Collapse all

Employment (2)

Krebsliga Beider Basel: Basel, CH

2020-01-01 to present | Leiterin Vorsorge und Früherkennung (Vorsorge und Früherkennung)
Employment
Source: Self-asserted source
Viviane Hess

University Hospital of Basel: Basel, CH

2012-08-01 to present | Senior Physician in Medical Oncology (Leitende Aerztin) (Medical Oncology)
Employment
Source: Self-asserted source
Viviane Hess

Works (37)

Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical Trial

JMIR Cancer
2023-08-28 | Journal article
DOI: 10.2196/38515
Contributors: Gunther Meinlschmidt; Astrid Grossert; Cornelia Meffert; Noa Roemmel; Viviane Hess; Christoph Rochlitz; Miklos Pless; Sabina Hunziker; Brigitta Wössmer; Ulfried Geuter et al.
Source: check_circle
Crossref

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events.

Frontiers in immunology
2023-04 | Journal article
DOI: 10.3389/fimmu.2023.1125111
PMID: 37122748
Contributors: Müller B; Bärenwaldt A; Herzig P; Zippelius A; Maul LV; Hess V; König D; Läubli H
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Group-based body psychotherapy improves appreciation of body awareness in post-treatment cancer patients: A non-randomized clinical trial.

Frontiers in psychology
2023-04 | Journal article
DOI: 10.3389/fpsyg.2023.956493
PMID: 37089722
PMC: PMC10117640
Contributors: Grossert A; Meffert C; Hess V; Rochlitz C; Pless M; Hunziker S; Wössmer B; Geuter U; Meinlschmidt G; Schaefert R
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events

Frontiers in immunology
2023-01 | Journal article
PMC: PMC10130408
Contributors: Müller B; Bärenwaldt A; Herzig P; Zippelius A; Maul L; Hess V; König D; Läubli H
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.

European journal of cancer (Oxford, England : 1990)
2022-10 | Journal article
DOI: 10.1016/j.ejca.2022.09.035
PMID: 36368252
Contributors: Panje C; Hayoz S; Eisterer W; Hess V; Thuss-Patience P; Schacher S; Dürr D; Wagner AD; Girschikofsky M; Eboulet E et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical Trial (Preprint)

2022-05-11 | Preprint
DOI: 10.2196/preprints.38515
Contributors: Gunther Meinlschmidt; Astrid Grossert; Cornelia Meffert; Noa Roemmel; Viviane Hess; Christoph Rochlitz; Miklos Pless; Sabina Hunziker; Brigitta Wössmer; Ulfried Geuter et al.
Source: check_circle
Crossref

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

The New England journal of medicine
2021-04 | Journal article
DOI: 10.1056/nejmoa2032125
PMID: 33789008
Contributors: Kelly RJ; Ajani JA; Kuzdzal J; Zander T; Van Cutsem E; Piessen G; Mendez G; Feliciano J; Motoyama S; Lièvre A et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.

BMC cancer
2020-02 | Journal article
DOI: 10.1186/s12885-020-6623-z
PMID: 32111181
PMC: PMC7048062
Contributors: Fehr M; Hawle H; Hayoz S; Thuss-Patience P; Schacher S; Riera Knorrenschild J; Dürr D; Knoefel WT; Rumpold H; Bitzer M et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered bodily interventions (KPTK): study protocol.

BMC psychology
2019-12 | Journal article
DOI: 10.1186/s40359-019-0357-1
PMID: 31888741
PMC: PMC6936033
Contributors: Grossert A; Meffert C; Hess V; Rochlitz C; Pless M; Hunziker S; Wössmer B; Geuter U; Meinlschmidt G; Schaefert R
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH.

BMJ open
2019-04 | Journal article
DOI: 10.1136/bmjopen-2018-024467
PMID: 31023750
PMC: PMC6501973
Contributors: Streckmann F; Hess V; Bloch W; Décard BF; Ritzmann R; Lehmann HC; Balke M; Koliamitra C; Oschwald V; Elter T et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).

Annals of oncology : official journal of the European Society for Medical Oncology
2018-06 | Journal article
DOI: 10.1093/annonc/mdy105
PMID: 29635438
Contributors: Ruhstaller T; Thuss-Patience P; Hayoz S; Schacher S; Knorrenschild JR; Schnider A; Plasswilm L; Budach W; Eisterer W; Hawle H et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13).

European journal of cancer (Oxford, England : 1990)
2018-04 | Journal article
DOI: 10.1016/j.ejca.2018.03.012
PMID: 29660598
Contributors: Wicki A; Brown N; Xyrafas A; Bize V; Hawle H; Berardi S; Cmiljanović N; Cmiljanović V; Stumm M; Dimitrijević S et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2018-01 | Journal article
DOI: 10.1200/jco.2017.74.8491
PMID: 29369731
PMC: PMC5844668
Contributors: Urech C; Grossert A; Alder J; Scherer S; Handschin B; Kasenda B; Borislavova B; Degen S; Erb J; Faessler A et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Web-based stress management for newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention study.

BMC cancer
2016-11 | Journal article
DOI: 10.1186/s12885-016-2866-0
PMID: 27809796
PMC: PMC5093991
Contributors: Grossert A; Urech C; Alder J; Gaab J; Berger T; Hess V
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort.

Journal of Cancer
2016-10 | Journal article
DOI: 10.7150/jca.16211
PMID: 27877227
PMC: PMC5118675
Contributors: Conen K; Hagmann R; Hess V; Zippelius A; Rothschild SI
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome.

Clinical colorectal cancer
2016-07 | Journal article
DOI: 10.1016/j.clcc.2016.07.008
PMID: 27687815
Contributors: Hess V; Winterhalder R; von Moos R; Widmer L; Stocker P; Jermann M; Herrmann R; Koeberle D
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience.

Journal of Cancer
2015-09 | Journal article
DOI: 10.7150/jca.13080
PMID: 26516363
PMC: PMC4615351
Contributors: Hagmann R; Hess V; Zippelius A; Rothschild SI
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06).

Annals of oncology : official journal of the European Society for Medical Oncology
2015-01 | Journal article
DOI: 10.1093/annonc/mdv011
PMID: 25605741
Contributors: Koeberle D; Betticher DC; von Moos R; Dietrich D; Brauchli P; Baertschi D; Matter K; Winterhalder R; Borner M; Anchisi S et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.

BMC cancer
2014-09 | Journal article
DOI: 10.1186/1471-2407-14-728
PMID: 25266049
PMC: PMC4242603
Contributors: Kasenda B; Bass A; Koeberle D; Pestalozzi B; Borner M; Herrmann R; Jost L; Lohri A; Hess V
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies.

European radiology
2012-08 | Journal article
DOI: 10.1007/s00330-012-2640-x
PMID: 22918564
Contributors: Schmidt N; Hess V; Zumbrunn T; Rothermundt C; Bongartz G; Potthast S
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2011-01 | Journal article
DOI: 10.1200/jco.2010.31.9715
PMID: 21205757
Contributors: Ruhstaller T; Pless M; Dietrich D; Kranzbuehler H; von Moos R; Moosmann P; Montemurro M; Schneider PM; Rauch D; Gautschi O et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy.

British journal of cancer
2010-09 | Journal article
DOI: 10.1038/sj.bjc.6605929
PMID: 20877359
PMC: PMC2990612
Contributors: Bernhard J; Dietrich D; Glimelius B; Hess V; Bodoky G; Scheithauer W; Herrmann R
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.

Annals of oncology : official journal of the European Society for Medical Oncology
2010-05 | Journal article
DOI: 10.1093/annonc/mdq242
PMID: 20444846
Contributors: Hess V; Pratsch S; Potthast S; Lee L; Winterhalder R; Widmer L; Cescato C; Lohri A; Jost L; Stillhart P et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).

The oncologist
2010-03 | Journal article
DOI: 10.1634/theoncologist.2009-0316
PMID: 20203173
PMC: PMC3227954
Contributors: Koeberle D; Montemurro M; Samaras P; Majno P; Simcock M; Limacher A; Lerch S; Kovàcs K; Inauen R; Hess V et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02).

Annals of oncology : official journal of the European Society for Medical Oncology
2009-05 | Journal article
DOI: 10.1093/annonc/mdp045
PMID: 19465425
Contributors: Ruhstaller T; Widmer L; Schuller JC; Roth A; Hess V; Mingrone W; von Moos R; Borner M; Pestalozzi BC; BalmerMajno S et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2009-02 | Journal article
DOI: 10.1007/s00520-008-0570-6
PMID: 19198893
Contributors: Ribi K; Koeberle D; Schuller JC; Honegger H; Roth A; Hess V; Moosmann P; von Moos R; Borner M; Lombriser N et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

[Surveillance after primary resection of esophageal, gastric, pancreatic, hepatobiliary cancer and gastrointestinal stroma tumor (GIST)].

Therapeutische Umschau. Revue therapeutique
2008-06 | Journal article
DOI: 10.1024/0040-5930.65.6.347
PMID: 18622959
Contributors: Hess V
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

[Adjuvant!Online--an Internet-based decision tool for adjuvant chemotherapy in early breast cancer].

Therapeutische Umschau. Revue therapeutique
2008-04 | Journal article
DOI: 10.1024/0040-5930.65.4.201
PMID: 18622911
Contributors: Hess V
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.

Annals of oncology : official journal of the European Society for Medical Oncology
2008-03 | Journal article
DOI: 10.1093/annonc/mdn058
PMID: 18349029
Contributors: Borner M; Koeberle D; Von Moos R; Saletti P; Rauch D; Hess V; Trojan A; Helbling D; Pestalozzi B; Caspar C et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.

British journal of cancer
2008-03 | Journal article
DOI: 10.1038/sj.bjc.6604297
PMID: 18349837
PMC: PMC2359632
Contributors: Koeberle D; Burkhard R; von Moos R; Winterhalder R; Hess V; Heitzmann F; Ruhstaller T; Terraciano L; Neuweiler J; Bieri G et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.

The Lancet. Oncology
2008-02 | Journal article
DOI: 10.1016/s1470-2045(08)70001-9
PMID: 18249033
Contributors: Hess V; Glimelius B; Grawe P; Dietrich D; Bodoky G; Ruhstaller T; Bajetta E; Saletti P; Figer A; Scheithauer W et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Interleukin-2-based biochemotherapy for patients with stage IV melanoma: long-term survivors outside a clinical trial setting.

Oncology
2007-01 | Journal article
DOI: 10.1159/000120029
PMID: 18332650
Contributors: Hess V; Herrmann R; Veelken H; Schwabe M
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.

Oncology
2006-01 | Journal article
DOI: 10.1159/000100449
PMID: 17344671
Contributors: Gick U; Rochlitz C; Mingrone W; Pestalozzi B; Rauch D; Ballabeni P; Lanz D; Hess V; Aebi S
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Infection with human herpesvirus 8 and transplant-associated gammopathy.

Transplantation
2004-05 | Journal article
DOI: 10.1097/01.tp.0000129065.31427.96
PMID: 15239620
Contributors: Regamey N; Hess V; Passweg J; Hess C; Steiger J; Erb P; Cathomas G; Tamm M
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2004-03 | Journal article
DOI: 10.1200/jco.2004.08.078
PMID: 15020606
Contributors: Hess V; A'Hern R; Nasiri N; King DM; Blake PR; Barton DP; Shepherd JH; Ind T; Bridges J; Harrington K et al.
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology
2003-04 | Journal article
DOI: 10.1093/annonc/mdg176
PMID: 12649113
Contributors: Hess V; Verrill MW; Bomphray CC; Vaughan MM; Allen M; Gore ME
Source: Self-asserted source
Viviane Hess via Europe PubMed Central

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2003-01 | Journal article
DOI: 10.1200/jco.2003.04.029
PMID: 12506172
Contributors: Hess V; Salzberg M; Borner M; Morant R; Roth AD; Ludwig C; Herrmann R
Source: Self-asserted source
Viviane Hess via Europe PubMed Central
How many people are using ORCID?